PROS1 and ovarian serous carcinoma: There is good evidence that CCNE1 is the correct call since Cyclin E is a key cell cycle protein and its amplification and over expression has been previously identified as a key driver of patient response to chemotherapy in serous ovarian carcinoma [14].